This HTML5 document contains 129 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
n8http://dx.doi.org/10.1158/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q40033522
rdf:type
wikibase:Item
schema:description
articol științific 2007年論文 artigo científico bilimsel makale บทความทางวิทยาศาสตร์ научни чланак 2007年論文 სამეცნიერო სტატია wissenschaftlicher Artikel artículo científico publicado en 2007 naučni članak wetenschappelijk artikel 2007年论文 2007年论文 article scientific scienca artikolo tieteellinen artikkeli научная статья artikull shkencor scientific article published on December 2007 2007年論文 article científic 2007年論文 tudományos cikk artigo científico artykuł naukowy 2007 nî lūn-bûn 2007년 논문 2007年论文 articolo scientifico artikel ilmiah article scientifique επιστημονικό άρθρο мақолаи илмӣ научни чланак vitenskapelig artikkel vědecký článek 2007年论文 artículu científicu espublizáu en 2007 bài báo khoa học مقالة علمية نشرت في ديسمبر 2007 ডিসেম্বর ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научна статия artigo científico 2007年論文 scientific article published on December 2007 2007年の論文 vetenskaplig artikel наукова стаття, опублікована в грудні 2007 vitskapeleg artikkel 2007年论文 2007年论文 videnskabelig artikel teaduslik artikkel vedecký článok artikulong pang-agham scientific article published on December 2007 מאמר מדעי
p:P577
wds:Q40033522-9C494CB2-269D-406F-96A0-B7D498AA20C7
wdt:P577
2007-12-01T00:00:00Z
p:P407
wds:Q40033522-23C9B77B-6C77-421C-834D-B7B2D127F58E
wdt:P407
wd:Q1860
p:P2093
wds:Q40033522-B98686CF-66DE-443C-A2FA-C77863D0F0E5 wds:Q40033522-A33B4556-D2C7-476F-96AA-CD3A9431B555 wds:Q40033522-93E3873C-6718-4EDD-A64A-D7D1226B221D wds:Q40033522-94012117-0ADA-48D4-9485-0A64C3485003 wds:Q40033522-7E871D4C-E143-4A69-A3B8-1752E9B25A78 wds:Q40033522-7EA24A4C-6350-456E-AD2F-D05FC7A6348D wds:Q40033522-7A65AECE-EA54-4F80-A2AC-78E425B09884 wds:Q40033522-71C25228-C71F-42EB-9D61-84706F7B22C3 wds:Q40033522-76AF60EA-6A9C-4C1C-B6E6-63021E8A5CF7 wds:Q40033522-57950024-DF5E-4E4C-99B7-E6DAF65656E5 wds:Q40033522-28540772-C4AB-4DE4-9264-62EF6D5CC804 wds:Q40033522-238FB442-DA6C-494A-97EC-61AD48B8EEF4 wds:Q40033522-1DEF23ED-6CFA-41B5-BE16-F7F21B12D858 wds:Q40033522-09E43D90-57A6-41D6-8859-F3375F9188D2
wdt:P2093
Takeshi Shimamura Irene W Althaus Kreshnik Zejnullahu Kwok-Kin Wong Geoffrey I Shapiro Christopher-Michael Gale Jeffrey A Engelman Andrea J Gonzales James M Nelson Patrick W Vincent George N Naumov James E Bradner Feng Zhao Eugene Lifshits
rdfs:label
PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib
skos:prefLabel
PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib
schema:name
PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib
p:P50
wds:Q40033522-7C05D959-15A9-4237-A6BA-95CED87111F8 wds:Q40033522-5D5D1538-2FC9-40ED-9F25-EBDA59DCE7E1 wds:Q40033522-AFFFC2BF-E7E2-47EE-8A89-6926A0007EAA wds:Q40033522-251107D4-683F-4D12-86CF-45C121A7722B
wdt:P50
wd:Q47451221 wd:Q88721314 wd:Q74766165 wd:Q55130361
p:P1476
wds:Q40033522-FEFFA31D-CCD5-4C61-9D6A-F2A9875876B7
wdt:P1476
PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib
p:P304
wds:Q40033522-C117133A-A197-46CC-8D4D-8B0BD35322E7
wdt:P304
11924-11932
p:P31
wds:Q40033522-515B56A4-6A5C-4EE2-9F62-8398D2E979A8
wdt:P31
wd:Q13442814
p:P921
wds:Q40033522-3C238017-11B4-41A2-AF4D-D212D6E7B9C8 wds:Q40033522-4FE680DB-9BFB-47BA-A3B3-C086EC04974F
wdt:P921
wd:Q47912 wd:Q415271
p:P698
wds:Q40033522-1139B704-0596-4896-AB73-EFAF0A045997
wdtn:P698
n12:18089823
wdt:P698
18089823
p:P1433
wds:Q40033522-57B77671-E756-4F14-B5FF-A8A91B4F8999
wdt:P1433
wd:Q326097
p:P433
wds:Q40033522-C73E920C-5835-4194-AF7B-27B0945008B7
p:P478
wds:Q40033522-EB94A468-DD4E-45F8-95CE-C8EC82FDEF1F
wdt:P433
24
wdt:P478
67
p:P356
wds:Q40033522-D6FED6B8-73D7-4BCB-A969-4F6D6DA752A3
wdtn:P356
n8:0008-5472.CAN-07-1885
wdt:P356
10.1158/0008-5472.CAN-07-1885
p:P5875
wds:Q40033522-D77BE258-E7AB-4D7D-BD8A-9CCFF0C276E1
wdt:P5875
5758679